ITMCTR2100005034Not yet recruitingPhase 4
Hospital centralized monitoring of clinical safety of Shenkang Injection after marketing
The First Affiliated Hospital of He'nan University of Chinese Medicine0 sitesStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Phase 4
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational study
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •During the monitoring period, inpatients receiving Shenkang injection treatment in each monitoring hospital.
Exclusion Criteria
- •Inpatients who are unable to collect the information needed for this study.
Investigators
Similar Trials
Recruiting
Phase 4
Post-marketing hospital centralized monitoring of clinical safety of Shuganning injectioAdverse drug reactionsITMCTR2100004833The First Affiliated Hospital of Henan University of Chinese Medicine
Completed
Not Applicable
A Multicenteric study to estimate the burden of rotavirus gastroenteritis among hospitalization due to diarrhea.CTRI/2012/03/002475Shantha Biotechnics Limited2,000
Not yet recruiting
Phase 4
Hospital Centralized Monitoring of Post-market Clinical Safety of Guipi MixtureSleep DisordersG47.900ITMCTR2024000037Anning First People's Hospital
Completed
Not Applicable
Hospital-based, Prospective, MulticentreSurveillance to determine the incidence ofintussusception in children aged < 15 Years inGermanyK56.1K38.8Other specified diseases of appendixIntussusceptionDRKS00000359Ruhr-Universität BochumAbteilung für Medizinische Informatik, Biometrie und Epidemiologie1,593
Completed
Not Applicable
Surveillance systems for healthcare-associated infection in high and upper-middle income countries: A Scoping Reviewhealthcare-associated infectionJPRN-UMIN000036035ational Center for Global Health and Medicine